Enzo Biochem (NYSE:ENZ) Full Year 2024 Results Key Financial Results Revenue: US$31.9m (up 2.7% from FY 2023). Net loss: US$9.82m (loss narrowed by 61% from FY 2023). US$0.19 loss per share (improved...
Source LinkEnzo Biochem (NYSE:ENZ) Full Year 2024 Results Key Financial Results Revenue: US$31.9m (up 2.7% from FY 2023). Net loss: US$9.82m (loss narrowed by 61% from FY 2023). US$0.19 loss per share (improved...
Source Link
Comments